Expanded Access for Iberdomide

Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam

NCT02800824 ·Status: COMPLETED ·Phase: PHASE1

Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection

NCT04978051 ·Status: COMPLETED ·Phase: PHASE2

Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

NCT03373903 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

NCT03538301 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT06360094 ·Status: TERMINATED ·Phase: PHASE2

A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)

NCT07366034 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.

NCT04348383 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

NCT05154240 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS

NCT04429555 ·Status: COMPLETED ·Phase: PHASE2

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

NCT07441408 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

NCT04396756 ·Status: COMPLETED ·Phase: PHASE2

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172482 ·Status: COMPLETED

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321420 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population

NCT03213080 ·Status: WITHDRAWN

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury

NCT04375397 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

NCT06589219 ·Status: RECRUITING ·Phase: PHASE1

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

NCT03114969 ·Status: COMPLETED

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.

NCT03422068 ·Status: COMPLETED ·Phase: PHASE1

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

NCT03502902 ·Status: COMPLETED ·Phase: PHASE1

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

NCT05321082 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study).

NCT05010876 ·Status: COMPLETED ·Phase: PHASE2

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

NCT05870956 ·Status: COMPLETED

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

NCT07121413 ·Status: RECRUITING ·Phase: PHASE2

A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma

NCT01987492 ·Status: COMPLETED ·Phase: PHASE2

INB03 for the Treatment of Pulmonary Complications From COVID-19

NCT04370236 ·Status: TERMINATED ·Phase: PHASE2/PHASE3